Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Equity (Unaudited)

v3.22.0.1
Condensed Consolidated Statements of Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings/ (Loss)
Accumulated Other Comprehensive Income/(Loss)
Employees
Common Stock
Executive Officer
Common Stock
Director
Common Stock
Beginning balance (in shares) at Mar. 31, 2020   32,916,818            
Beginning balance at Mar. 31, 2020 $ 346,439 $ 33 $ 227,741 $ 182,559 $ (63,894)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock in exercise of stock options (in shares)   81,995            
Issuance of common stock in exercise of stock options 437 $ 0 437          
Issuance of common stock (in shares)           39,458 63,477 13,520
Stock compensation expense 1,133   1,133          
Repurchase of employee stock units on vesting (557)   (557)          
Net income/(loss) (6,085)     (6,085)        
Foreign currency translation adjustment 9,475       9,475      
Other (380)       (380)      
Ending balance (in shares) at Jun. 30, 2020   33,115,268            
Ending balance at Jun. 30, 2020 350,462 $ 33 228,754 176,474 (54,799)      
Beginning balance (in shares) at Mar. 31, 2020   32,916,818            
Beginning balance at Mar. 31, 2020 346,439 $ 33 227,741 182,559 (63,894)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income/(loss) 1,928              
Ending balance (in shares) at Dec. 31, 2020   33,186,218            
Ending balance at Dec. 31, 2020 379,582 $ 33 230,450 184,487 (35,388)      
Beginning balance (in shares) at Jun. 30, 2020   33,115,268            
Beginning balance at Jun. 30, 2020 350,462 $ 33 228,754 176,474 (54,799)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock in exercise of stock options (in shares)   1,344            
Issuance of common stock in exercise of stock options 15   15          
Issuance of common stock (in shares)           33,789 6,005 13,392
Stock compensation expense 1,358   1,358          
Repurchase of employee stock units on vesting (129)   (129)          
Net income/(loss) 1,838     1,838        
Foreign currency translation adjustment 5,254       5,254      
Other (199)       (199)      
Ending balance (in shares) at Sep. 30, 2020   33,169,798            
Ending balance at Sep. 30, 2020 358,599 $ 33 229,998 178,312 (49,744)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock in exercise of stock options (in shares)   0            
Issuance of common stock in exercise of stock options 16   16          
Issuance of common stock (in shares)           1,867   14,553
Stock compensation expense 430   430          
Repurchase of employee stock units on vesting (2)   (2)          
Net income/(loss) 6,175     6,175        
Foreign currency translation adjustment 14,516       14,516      
Other (152)   8   (160)      
Ending balance (in shares) at Dec. 31, 2020   33,186,218            
Ending balance at Dec. 31, 2020 $ 379,582 $ 33 230,450 184,487 (35,388)      
Beginning balance (in shares) at Mar. 31, 2021 33,225,808 33,225,808            
Beginning balance at Mar. 31, 2021 $ 378,872 $ 33 231,322 183,436 (35,919)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock in exercise of stock options (in shares)   8,100            
Issuance of common stock in exercise of stock options 97   97          
Issuance of common stock (in shares)           23,858 42,326 7,368
Stock compensation expense 1,178   1,178          
Repurchase of employee stock units on vesting (548)   (548)          
Net income/(loss) (340)     (340)        
Foreign currency translation adjustment 4,195     0 4,195      
Other (64)     0 (64)      
Ending balance (in shares) at Jun. 30, 2021   33,307,460            
Ending balance at Jun. 30, 2021 $ 383,390 $ 33 232,049 183,096 (31,788)      
Beginning balance (in shares) at Mar. 31, 2021 33,225,808 33,225,808            
Beginning balance at Mar. 31, 2021 $ 378,872 $ 33 231,322 183,436 (35,919)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income/(loss) $ 11,407              
Ending balance (in shares) at Dec. 31, 2021 33,341,899 33,341,899            
Ending balance at Dec. 31, 2021 $ 388,560 $ 33 233,555 194,843 (39,871)      
Beginning balance (in shares) at Jun. 30, 2021   33,307,460            
Beginning balance at Jun. 30, 2021 383,390 $ 33 232,049 183,096 (31,788)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)           10,687 7,344 8,352
Stock compensation expense 1,246   1,246          
Repurchase of employee stock units on vesting (14)   (14)          
Net income/(loss) 477     477        
Foreign currency translation adjustment (7,625)       (7,625)      
Other 51   (1) 1 51      
Ending balance (in shares) at Sep. 30, 2021   33,333,843            
Ending balance at Sep. 30, 2021 377,525 $ 33 233,280 183,574 (39,362)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)           52   8,004
Stock compensation expense 275   275          
Net income/(loss) 11,270     11,270        
Foreign currency translation adjustment (413)       (413)      
Other $ (97)     (1) (96)      
Ending balance (in shares) at Dec. 31, 2021 33,341,899 33,341,899            
Ending balance at Dec. 31, 2021 $ 388,560 $ 33 $ 233,555 $ 194,843 $ (39,871)